BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12119140)

  • 1. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
    Hamdy ME; El-Gibaly SM; Montasser AM
    Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
    Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective properties of rifampin-resistant rough mutants of Brucella melitensis.
    Adone R; Ciuchini F; Marianelli C; Tarantino M; Pistoia C; Marcon G; Petrucci P; Francia M; Riccardi G; Pasquali P
    Infect Immun; 2005 Jul; 73(7):4198-204. PubMed ID: 15972510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
    Jiménez de Bagüés MP; Elzer PH; Jones SM; Blasco JM; Enright FM; Schurig GG; Winter AJ
    Infect Immun; 1994 Nov; 62(11):4990-6. PubMed ID: 7927779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
    Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
    Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
    Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
    APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
    Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.
    Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M
    Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams.
    Jiménez de Bagüés MP; Barberán M; Marín CM; Blasco JM
    Vaccine; 1995 Feb; 13(3):301-4. PubMed ID: 7631517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis).
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Adone R
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):43-55. PubMed ID: 16112746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.